Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies

v2.4.0.8
Commitments and Contingencies
 6 Months Ended
Dec. 31, 2013
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Disclosure [Text Block]
13.
Commitments and Contingencies
 
Under the terms of the Settlement Agreement described in Note 6 – Significant Vendor above, the Company is obligated to engage Fraunhofer to perform at least $3 million of research and development work as directed by iBio by December 31, 2015. As of December 31, 2013, the Company had entered into research services agreements with Fraunhofer representing approximately $1.6 million of the $3 million commitment. As discussed in Note 15 - Subsequent Events, the Company terminated a $1.5 million research services agreement with Fraunhofer.  After such termination, the Company will have incurred $0.6 million of research services toward the $3 million commitment.